Aerovate Therapeutics Inc
NASDAQ:AVTE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aerovate Therapeutics Inc
NASDAQ:AVTE
|
US |
|
C
|
Concert Pharmaceuticals Inc
F:73C
|
US |
|
F
|
First Foundation Inc
F:8F1
|
US |
Dividends
Dividend Yield
Aerovate Therapeutics Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Aerovate Therapeutics Inc
AVTE have
decreased
by 0%.
Payout Ratio
Aerovate Therapeutics Inc
| Current Payout | |
| Min Payout | |
| Max Payout | |
| Average Payout | |
| Median Payout |
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
AVTE is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
AVTE Price
Aerovate Therapeutics Inc
| Average Annual Return | 25.29% |
| Standard Deviation of Annual Returns | 106.93% |
| Max Drawdown | -100% |
| Market Capitalization | 75.7m USD |
| Shares Outstanding | 828 143 |
| Percentage of Shares Shorted | 1.15% |
AVTE Return Decomposition
Main factors of price return
Stock Splits
AVTE's latest stock split occurred on Apr 29, 2025
The company executed a 1-for-35 stock split, meaning that for every 35 shares held, investors received 1 new share.
The adjusted shares began trading on Apr 29, 2025. This was the only stock split in AVTE's history.